History of severe hypersensitivity reaction to any monoclonal antibody
History of severe hypersensitivity reaction to any monoclonal antibody
History of severe hypersensitivity reaction to any monoclonal antibody
History of severe hypersensitivity reaction to any monoclonal antibody
Patients with a history severe (>= grade 3) hypersensitivity reaction to a monoclonal antibody are ineligible
EXCLUSION CRITERIA FOR STRATUM C: Patients with a history severe (>= grade 3) hypersensitivity reaction to a monoclonal antibody are ineligible
History of grade 3-4 immediate hypersensitivity reaction to paclitaxel
Patients with a prior hypersensitivity reaction to sargramostim
At least 4 weeks from end of monoclonal antibody therapy
History of severe hypersensitivity reaction to any monoclonal antibody
No history of severe hypersensitivity to a monoclonal antibody
History of severe hypersensitivity reaction to any monoclonal antibody
Have a known immediate or delayed hypersensitivity reaction or idiosyncrasy to talimogene laherparepvec or any of its components or nivolumab, or history of severe hypersensitivity reaction to any monoclonal antibody
